key: cord-1032376-99mxnvlo
authors: Mimoso, Jorge
title: O impacto da COVID-19 na admissão por síndromes coronárias agudas
date: 2021-10-29
journal: Rev Port Cardiol
DOI: 10.1016/j.repc.2021.10.004
sha: d1150f3b641ffc4c6790512c5a4ef449f06f87dd
doc_id: 1032376
cord_uid: 99mxnvlo

nan

The coronavirus disease 2019 (COVID-19) outbreak has become a worldwide healthcare emergency, and has had a particular impact on the diagnostic and treatment pathways for patients presenting with acute coronary syndromes (ACS). 1 Globally, there was a reduction in the number of admissions for ACS due to fear of contagion in hospitals and access to emergency medical services (EMS) was discouraged, as they were focused on COVID-19 and these services allocated most health resources to the pandemic. 2,3 At the same time, there was an increase in time from the first medical contact to coronary revascularization in patients with acute STelevation myocardial infarctions (STEMI). This is a very important issue because the delay in reperfusion therapies has a negative prognostic impact. 4 In this issue of the Journal, Calvão et al. 5 In the clinical course there was no difference in relation to Killip class, the maximum Troponin I was significantly higher in the pandemic group (19 439±70 265ng/L vs.10 222±36870 ng/L, p=0.03) and there were also significantly more patients with left ventricular systolic dysfunction at discharge (58.0% vs. 35.0%, p=0.01). There was a higher proportion of patients in the pandemic group with in-hospital complications (23.9% vs. 13.8%, p=0.11) and in-hospital (5.6% vs 1.3%, p=0.15) and 30 days (7.0% vs.

2.5%, p=0.18) mortality. The difference in complication rate may have to do with the higher proportion of STEMI in the pandemic group and the delays in reperfusion. They did not reach statistical significance due to the small sample size.

The authors recognize some limitations to the study as it was a single-center study, with a relatively low number of patients, acute morbidity and mortality may be underestimated, since patients that died in the pre-hospital phase/emergency room or were admitted at other intensive care units in the same hospital were not included.

This work emphasizes the importance of carrying out multicenter studies and registries that enable larger samples to be more easily attained in terms of statistical significance. Considering that time is myocardial, health services must have organizational models that convey confidence and security to patients so that, in case of symptoms suggestive of ACS, they immediately call the emergency department for

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

The fall in acute coronary syndrome admissions during the COVID-19

Portuguese lockdown

Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center: Preliminary Data

The Impact of COVID-19 Pandemic in Acute Coronary Syndromes Admissions in a Tertiary Care Hospital in Portugal

The author has no conflicts of interest to declare.